F32 Z61
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Depression & Trauma Group: Age of mother > 17; Experience of abuse in childhood; At least one depressive episode in the past; Depression remitted; Medication stable for 2 weeks; Age of child: 5-11 years; Mother and child live together; Sufficient knowledge of German Group depression without trauma: Age of mother > 17; At least one depressive episode in the past; Depression remitted; Medication stable for 2 weeks; Age of child: 5-11 years; Mother and child live together; Sufficient knowledge of German Control group Age of mother > 17; Age of child: 5-11 years; Mother and child live together; Sufficient knowledge of German
Exclusion criteria
Exclusion criteria: Trauma & Depression Group Acute suicidal tendency Schizophrenic or schizoaffective disorder, mania, bipolar disorder, borderline personality disorder, antisocial personality disorder, dementia, substance-related addiction in the last six months (exception nicotine), benzodiacepine medication Mental retardation or physical disability of mother or child, Danger to child welfare; Organic Diseases of mother or child interfering with study-related assessment. Depression without trauma Group Acute suicidal tendency Experience of abuse in childhood Schizophrenic or schizoaffective disorder, mania, bipolar disorder, borderline personality disorder, antisocial personality disorder, dementia, substance-related addiction in the last six months (exception nicotine), benzodiacepine medication Mental retardation or physical disability of mother or child, Danger to child welfare; Organic Diseases of mother or child interfering with study-related assessment. Control group Past or present psychiatric disorder Acute suicidal tendency Experience of abuse in childhood Schizophrenic or schizoaffective disorder, mania, bipolar disorder, borderline personality disorder, antisocial personality disorder, dementia, substance-related addiction in the last six months (exception nicotine), benzodiacepine medication Mental retardation or physical disability of mother or child, Danger to child welfare; Organic Diseases of mother or child interfering with study-related assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maternal Outcome: Maternal sensitivity (Emotional Availability Scales): Difference between Baseline and Follow-Up-1 (Measurement after intervention). Child Outcome: Child Life Quality (KidScreen): Difference between Baseline and Follow-Up-1 (Measurement after intervention). | — |
Secondary
| Measure | Time frame |
|---|---|
| Maternal Secondary Outcomes: - Maternal Sensitivity (Emotional Availability Scales): Difference between Baseline and Follow-Up II (6 months after intervention). - Maternal Intrusivity and Hostility (Emotional Availability Scales), Differences between Baseline and Follow-Up-I / Follow-Up-II. - Maternal Psychopathology (Hamilton rating scale for depression, Symptom Checklist-90-R, Beck Depression Inventory-II, Interpersonal Reactivity Index, Parental Stress Inventory, Scorewerte), Maternal Abuse Potential (Child Abuse Potential Inventory): Differences between Baseline and Follow-Up-I / Follow-Up-II. Child Secondary Outcomes: - Life Quality (KIDSCREEN): Difference between Baseline and Follow Up II (6 months after intervention) - Child Responsivity (Emotional Availability Scales), Differences between Baseline and Follow-Up-I / Follow-Up-II - Child Behavior (Eyberg Child Behavior Inventory, Child Behavior Checklis, Teacher Ration Form): Differences between Baseline and Follow-Up-I (immediately after intervention) / Follow-Up-II (6 months after intervention) | — |
Countries
Germany
Contacts
Psychiatrische Universitätsklinik der Charité im St. Hedwig Krankenhaus